- Home
- PC vs CARM Comparison
PC vs CARM Comparison
Compare PC & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PC
- CARM
- Stock Information
- Founded
- PC 2012
- CARM 2016
- Country
- PC Singapore
- CARM United States
- Employees
- PC N/A
- CARM N/A
- Industry
- PC Restaurants
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- PC Consumer Discretionary
- CARM Health Care
- Exchange
- PC Nasdaq
- CARM Nasdaq
- Market Cap
- PC 12.4M
- CARM 12.2M
- IPO Year
- PC 2024
- CARM N/A
- Fundamental
- Price
- PC $7.00
- CARM $0.32
- Analyst Decision
- PC
- CARM Hold
- Analyst Count
- PC 0
- CARM 5
- Target Price
- PC N/A
- CARM $0.90
- AVG Volume (30 Days)
- PC 35.1K
- CARM 24.8M
- Earning Date
- PC 01-01-0001
- CARM 08-07-2025
- Dividend Yield
- PC N/A
- CARM N/A
- EPS Growth
- PC N/A
- CARM N/A
- EPS
- PC N/A
- CARM N/A
- Revenue
- PC $3,345,964.00
- CARM $10,767,000.00
- Revenue This Year
- PC N/A
- CARM N/A
- Revenue Next Year
- PC N/A
- CARM N/A
- P/E Ratio
- PC N/A
- CARM N/A
- Revenue Growth
- PC N/A
- CARM N/A
- 52 Week Low
- PC $5.11
- CARM $0.14
- 52 Week High
- PC $51.57
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- PC 52.04
- CARM 52.65
- Support Level
- PC $6.46
- CARM $0.21
- Resistance Level
- PC $7.51
- CARM $0.56
- Average True Range (ATR)
- PC 0.63
- CARM 0.04
- MACD
- PC 0.02
- CARM 0.02
- Stochastic Oscillator
- PC 68.57
- CARM 31.79
About PC Premium Catering (Holdings) Limited Ordinary Shares
Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.